Keyphrases
ACR Appropriateness Criteria
7%
Acute Ischemic Stroke
13%
Aging
13%
Alzheimer's Dementia
9%
Alzheimer's Disease
100%
Alzheimer's Disease Biomarkers
14%
Alzheimer's Disease Pathology
14%
Amyloid beta
7%
Amyloid Burden
10%
Amyloid Deposition
8%
Amyloid Imaging
12%
Amyloid PET
8%
Amyloid Positron Emission Tomography
9%
Aneurysm
15%
APOE4
7%
Apolipoprotein E
8%
Apparent Diffusion Coefficient
7%
Atrophy
11%
Autosomal Dominant Alzheimer's Disease
33%
Body Mass Index
7%
Brain Aging
10%
Brain MRI
8%
Brain Regions
9%
Brain Structure
10%
Brain Tumor
8%
Brain Volume
11%
Catheter
7%
Central Nervous System
8%
Cerebral Blood Flow
7%
Cerebrospinal Fluid
33%
Cerebrospinal Fluid Biomarkers
11%
Clinical Outcomes
13%
Clinical Trials
10%
Cognitive Decline
16%
Cognitive Impairment
18%
Cognitively Normal
20%
Computed Tomography
16%
Contrast Enhancement
10%
Cortical Thickness
9%
Dementia
10%
Diffusion Magnetic Resonance Imaging (dMRI)
14%
Diffusion Tensor Imaging
19%
Dominantly Inherited Alzheimer Network
13%
Dominantly Inherited Alzheimer's Disease
12%
Early Alzheimer's Disease
8%
Endovascular
7%
Endovascular Thrombectomy
7%
Endovascular Treatment
9%
Fractional Anisotropy
10%
Functional Connectivity
23%
Functional Magnetic Resonance Imaging
26%
Gray Matter
12%
Gray Matter Volume
9%
Healthy Controls
9%
Hippocampal Volume
10%
Hippocampus
8%
Human Brain
12%
Human Connectome Project
16%
Imaging Biomarkers
11%
Imaging Studies
7%
Intracranial Aneurysm
12%
Longitudinal Change
8%
Magnetic Resonance Imaging
73%
Mild Cognitive Impairment
8%
Multiple Sclerosis
19%
Mutation Carriers
15%
Neurodegeneration
12%
Neuroimaging
19%
Neuroinflammation
8%
Non-carriers
11%
Nonhuman Primate
8%
Obesity
7%
Older Adults
21%
Pediatric
11%
Pediatric multiple Sclerosis
8%
Pediatric Patients
9%
Phosphorylated tau
9%
Physical Activity
7%
Pipeline Embolization Device
7%
Pittsburgh Compound B
14%
Positron Emission Tomography
24%
Radiologists
14%
Radiology
8%
Radiotracer
7%
Region of Interest
9%
Resting State
7%
Resting-state Functional Connectivity (rs-FC)
22%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
27%
Sporadic Alzheimer's Disease
34%
Standardized Uptake Value
8%
Structural Magnetic Resonance Imaging (sMRI)
7%
Symptom Onset
13%
T2-weighted Imaging (T2WI)
8%
Tau Pathology
7%
Tau Positron Emission Tomography
8%
Temporal Lobe
10%
Tumor
13%
White Matter
27%
White Matter Hyperintensities
9%
White Matter Integrity
10%
Medicine and Dentistry
Alzheimer's Disease
81%
Amyloid Protein
44%
Aneurysm
26%
Angiography
6%
Angioplasty
6%
Apoplexy
31%
Arnold Chiari Malformation
6%
Arteriovenous Malformation
5%
Autosomal Dominant Inheritance
17%
Biological Marker
23%
Bleeding
10%
Brain Ischemia
18%
Carbon 11
5%
Cerebral Hemorrhage
7%
Cerebrospinal Fluid
23%
Clinical Trial
7%
Cognitive Defect
7%
Computer Assisted Tomography
15%
Diffusion MRI
9%
Diffusion Tensor Imaging
5%
Diseases
30%
Dural Arteriovenous Fistula
7%
Embolization
17%
Endovascular Coiling
5%
Functional Connectivity
9%
Functional Magnetic Resonance Imaging
9%
Ganglioglioma
8%
Gray Matter
8%
Infarction
7%
Infection
5%
Intracranial Aneurysm
13%
Intracranial Tumor
8%
Magnetic Resonance Imaging
70%
Magnetic Resonance Imaging
20%
Mechanical Thrombectomy
5%
Meta-Analysis
5%
Multiple Sclerosis
12%
Neck
5%
Neoplasm
20%
Neurodegeneration
6%
Neuroinflammation
5%
Pediatrics
25%
Pediatrics Patient
8%
Percutaneous Thrombectomy
7%
Personalized Medicine
5%
Pittsburgh Compound B
10%
Polyethylene Terephthalate
16%
Positron Emission Tomography
28%
Prevalence
5%
Radioactive Tracer
10%
Radiology
16%
Sickle-Cell Disease
5%
Stenosis
8%
Subarachnoid Hemorrhage
6%
Tau
27%
Thrombectomy
7%
Traumatic Brain Injury
7%